ClearStream floats on AIM (Alternative Investment Market), raising Euros7 million
This article was originally published in Clinica
Irish company ClearStream Technologies has raised Euros7m ($9m) through a flotation on London's Alternative Investment Market (AIM). The Enniscorthy, County Wexford firm intends to invest the proceeds in R&D to build its pipeline of coronary, peripheral and carotid angioplasty products. It will also make a number of senior appointments.
You may also be interested in...
Following hot on the heels of its Rapidly Manufactured Ventilator Specification document, the UK’s regulator has issued another speedy regulatory permit for fast production of respiratory assist devices.
Which drug candidates represent hope, and which hype? The Scrip team examine the COVID-19 pipeline, lessons from China, and some long term impacts on the sector.
China insists there is no double standard and won’t tolerate any quality issues in its centralized procurement process.